Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Executive Vice President | December 11, 2012 | December 13, 2012 |
| AbbVie Inc.ABBV · Entity 2800 | Vice Chairman | February 25, 2022 | March 01, 2022 |
| CrowdStrike Holdings, Inc.CRWD · Entity 1172 | Director | September 18, 2026 | September 22, 2026 |
| GENERAL DYNAMICS CORPGD · Entity 2916 | Director | September 16, 2026 | September 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date December 11, 2012 · Filed December 13, 2012
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 179,338 |
Ending reported balance
After 2012-12-11 transaction · row 7
7 source rows · reconciled sequenceRow 1 · 2012-12-11 · Exercise / conversion · Acquired 36,985 · Balance 216,323 Row 2 · 2012-12-11 · Exercise / conversion · Acquired 67,200 · Balance 283,523 Row 3 · 2012-12-11 · Exercise / conversion · Acquired 1,045 · Balance 284,568 Row 4 · 2012-12-11 · Exercise / conversion · Acquired 2,395 · Balance 286,963 Row 5 · 2012-12-11 · Exercise / conversion · Acquired 652 · Balance 287,615 Row 6 · 2012-12-11 · Exercise / conversion · Acquired 11,500 · Balance 299,115 Row 7 · 2012-12-11 · Sale · Disposed 119,777 · Balance 179,338 |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $46.34 · Expires 2015-02-17 | Direct | 0 |
Reported balance
After 2012-12-11 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2012-12-11 · Exercise / conversion · Disposed 36,985 · Balance 0 F1: Employee stock option granted pursuant to Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $52.54 · Expires 2017-02-15 | Direct | 0 |
Reported balance
After 2012-12-11 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2012-12-11 · Exercise / conversion · Disposed 67,200 · Balance 0 F1: Employee stock option granted pursuant to Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $58.16 · Expires 2013-02-13 | Direct | 0 |
Reported balance
After 2012-12-11 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2012-12-11 · Exercise / conversion · Disposed 1,045 · Balance 0 F2: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $52.74 · Expires 2014-02-19 | Direct | 0 |
Reported balance
After 2012-12-11 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2012-12-11 · Exercise / conversion · Disposed 2,395 · Balance 0 F2: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $59.01 · Expires 2013-02-13 | Direct | 0 |
Reported balance
After 2012-12-11 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2012-12-11 · Exercise / conversion · Disposed 652 · Balance 0 F2: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $46.60 · Expires 2021-02-17 | Direct | 38,333 |
Reported balance
After 2012-12-11 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2012-12-11 · Exercise / conversion · Disposed 11,500 · Balance 38,333 F3: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. |
Filing footnotes · ownership attribution and instrument terms
F1: Employee stock option granted pursuant to Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3.
F2: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.
F3: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
AbbVie Inc.
Report date February 25, 2022 · Filed March 01, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.01 par valueSEC Table I · non-derivative | Direct | 248,002 |
Reported balance
After 2022-02-25 transaction · row 1
1 source rowRow 1 · 2022-02-25 · Tax withholding · Disposed 40,490 · Balance 248,002 |
CrowdStrike Holdings, Inc.
Report date September 18, 2026 · Filed September 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A common stockSEC Table I · non-derivative | Direct | 38,724 |
Reported balance
After 2026-09-18 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-09-18 · Grant · Acquired 68 · Balance 38,724 F1: The shares represent fully vested RSUs issued in lieu of quarterly cash retainer(s) payable under the issuer's Outsider Director Compensation Policy. The RSUs immediately converted into shares of the issuer's Class A Common Stock. F2: On July 2, 2026, the Issuer executed a four-for-one stock split with a record date of June 25, 2026, effected in the form of a one-time special stock dividend on each share of the company's Class A common stock. F3: Includes shares to be issued in connection with the vesting of one or more RSUs. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares represent fully vested RSUs issued in lieu of quarterly cash retainer(s) payable under the issuer's Outsider Director Compensation Policy. The RSUs immediately converted into shares of the issuer's Class A Common Stock.
F2: On July 2, 2026, the Issuer executed a four-for-one stock split with a record date of June 25, 2026, effected in the form of a one-time special stock dividend on each share of the company's Class A common stock.
F3: Includes shares to be issued in connection with the vesting of one or more RSUs.
GENERAL DYNAMICS CORP
Report date September 16, 2026 · Filed September 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 13,792 |
Reported balance
After 2026-09-16 transaction · row 1
1 source rowRow 1 · 2026-09-16 · Grant · Acquired 105 · Balance 13,792 F1: Reflects stock received in lieu of director fees in accordance with outside directors' compensation program. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects stock received in lieu of director fees in accordance with outside directors' compensation program.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 24, 2016 Filed Jun 28, 2016 21:47 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 72,500 | $60.05 | $4,353,625.00 |
DisclosureSEC source: 0001179110-16-027030 · edgar.xml · nonDerivative · entry 12 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,538 Read SEC document |
| June 24, 2016 Filed Jun 28, 2016 21:47 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 25,000 | $60.04 | $1,501,000.00 |
DisclosureSEC source: 0001179110-16-027030 · edgar.xml · nonDerivative · entry 11 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,038 Read SEC document |
| June 24, 2016 Filed Jun 28, 2016 21:47 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 300 | $60.03 | $18,009.00 |
DisclosureSEC source: 0001179110-16-027030 · edgar.xml · nonDerivative · entry 10 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 293,038 Read SEC document |
| June 24, 2016 Filed Jun 28, 2016 21:47 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 100 | $60.03 | $6,002.50 |
DisclosureSEC source: 0001179110-16-027030 · edgar.xml · nonDerivative · entry 9 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 293,338 Read SEC document |
| June 24, 2016 Filed Jun 28, 2016 21:47 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 300 | $60.02 | $18,006.00 |
DisclosureSEC source: 0001179110-16-027030 · edgar.xml · nonDerivative · entry 8 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 293,438 Read SEC document |
| June 24, 2016 Filed Jun 28, 2016 21:47 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 1,100 | $60.01 | $66,011.00 |
DisclosureSEC source: 0001179110-16-027030 · edgar.xml · nonDerivative · entry 7 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 293,738 Read SEC document |
| June 24, 2016 Filed Jun 28, 2016 21:47 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 1,513 | $60.01 | $90,787.57 |
DisclosureSEC source: 0001179110-16-027030 · edgar.xml · nonDerivative · entry 6 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 294,838 Read SEC document |
| June 24, 2016 Filed Jun 28, 2016 21:47 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 83,893 | $60.00 | $5,033,580.00 |
DisclosureSEC source: 0001179110-16-027030 · edgar.xml · nonDerivative · entry 5 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 296,351 Read SEC document |
| June 24, 2016 Filed Jun 28, 2016 21:47 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionCommon stock, $0.01 par value | 38,333 | $24.21 | $927,972.93 |
DisclosureSEC source: 0001179110-16-027030 · edgar.xml · nonDerivative · entry 4 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 380,244 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 24, 2016 Filed Jun 28, 2016 21:47 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionCommon stock, $0.01 par value | 42,533 | $28.31 | $1,204,202.80 |
DisclosureSEC source: 0001179110-16-027030 · edgar.xml · nonDerivative · entry 3 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 341,911 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 24, 2016 Filed Jun 28, 2016 21:47 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionCommon stock, $0.01 par value | 38,940 | $28.13 | $1,095,191.39 |
DisclosureSEC source: 0001179110-16-027030 · edgar.xml · nonDerivative · entry 2 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,378 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 24, 2016 Filed Jun 28, 2016 21:47 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionCommon stock, $0.01 par value | 66,300 | $28.86 | $1,913,603.64 |
DisclosureSEC source: 0001179110-16-027030 · edgar.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,438 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2016 Filed Mar 8, 2016 22:23 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 100 | $56.15 | $5,615.00 |
DisclosureSEC source: 0001179110-16-021298 · edgar.xml · nonDerivative · entry 6 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,138 Read SEC document |
| March 08, 2016 Filed Mar 8, 2016 22:23 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 800 | $56.13 | $44,904.00 |
DisclosureSEC source: 0001179110-16-021298 · edgar.xml · nonDerivative · entry 5 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,238 Read SEC document |
| March 08, 2016 Filed Mar 8, 2016 22:23 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 300 | $56.12 | $16,836.00 |
DisclosureSEC source: 0001179110-16-021298 · edgar.xml · nonDerivative · entry 4 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,038 Read SEC document |
| March 08, 2016 Filed Mar 8, 2016 22:23 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 500 | $56.11 | $28,055.00 |
DisclosureSEC source: 0001179110-16-021298 · edgar.xml · nonDerivative · entry 3 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,338 Read SEC document |
| March 08, 2016 Filed Mar 8, 2016 22:23 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 3,400 | $56.10 | $190,740.00 |
DisclosureSEC source: 0001179110-16-021298 · edgar.xml · nonDerivative · entry 2 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,838 Read SEC document |
| March 08, 2016 Filed Mar 8, 2016 22:23 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 19,900 | $56.09 | $1,116,191.00 |
DisclosureSEC source: 0001179110-16-021298 · edgar.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,238 Read SEC document |
| February 29, 2016 Filed Mar 2, 2016 22:24 UTC | AbbVie Inc. ABBV · Entity 2800 | Tax withholdingCommon stock, $0.01 par value | 54,178 | $56.00 | $3,033,968.00 |
DisclosureSEC source: 0001179110-16-020683 · edgar.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,138 Read SEC document |
| February 18, 2016 Filed Feb 22, 2016 22:10 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantOption (right to buy) · Derivative | 78,450 | $0.00 Strike: $54.86 | $0.00 |
DisclosureSEC source: 0001179110-16-019786 · edgar.xml · derivative · entry 1 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,450 Underlying: Common stock · 78,450 shares Expires 2026-02-17 F1 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exerciseable in annual increments of 26,150 on 02/18/2017, 26,150 on 02/18/2018, and 26,150 on 02/18/2019. Read SEC document |
| November 04, 2015 Filed Dec 30, 2015 22:13 UTC | AbbVie Inc. ABBV · Entity 2800 | GiftCommon stock, $0.01 par value | 800 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-016810 · edgar.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,316 Read SEC document |
| March 02, 2015 Filed Mar 3, 2015 23:10 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 25,000 | $60.30 | $1,507,500.00 |
DisclosureSEC source: 0001179110-15-004098 · edgar.xml · nonDerivative · entry 3 Schumacher Laura J · CIK 0001319245 · EVP, Bus.Dev.,Ext.Aff.&GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,116 Read SEC document |
| February 28, 2015 Filed Mar 3, 2015 23:10 UTC | AbbVie Inc. ABBV · Entity 2800 | Tax withholdingCommon stock, $0.01 par value | 8,317 | $60.50 | $503,178.50 |
DisclosureSEC source: 0001179110-15-004098 · edgar.xml · nonDerivative · entry 2 Schumacher Laura J · CIK 0001319245 · EVP, Bus.Dev.,Ext.Aff.&GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,116 Read SEC document |
| February 27, 2015 Filed Mar 3, 2015 23:10 UTC | AbbVie Inc. ABBV · Entity 2800 | Tax withholdingCommon stock, $0.01 par value | 17,584 | $60.52 | $1,064,183.68 |
DisclosureSEC source: 0001179110-15-004098 · edgar.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · EVP, Bus.Dev.,Ext.Aff.&GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 307,433 Read SEC document |
| February 19, 2015 Filed Feb 23, 2015 22:11 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantOption (right to buy) · Derivative | 103,220 | $0.00 Strike: $58.88 | $0.00 |
DisclosureSEC source: 0001179110-15-003165 · edgar.xml · derivative · entry 2 Schumacher Laura J · CIK 0001319245 · EVP, Bus.Dev.,Ext.Aff.&GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,220 Underlying: Common stock · 103,220 shares Expires 2025-02-18 F2 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exerciseable in annual increments of 34,407 on 02/19/2016, 34,406 on 02/19/2017, and 34,407 on 02/19/2018. Read SEC document |
| February 19, 2015 Filed Feb 23, 2015 22:11 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon stock, $0.01 par value | 52,220 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-003165 · edgar.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · EVP, Bus.Dev.,Ext.Aff.&GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 325,017 F1 · shares: These securities represent performance vested restricted stock awards under the AbbVie 2013 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon AbbVie reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| November 12, 2014 Filed Nov 26, 2014 22:01 UTC | AbbVie Inc. ABBV · Entity 2800 | GiftCommon stock, $0.01 par value | 788 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-017221 · edgar.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · EVP, Bus.Dev.,Ext.Aff.&GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,797 Read SEC document |
| March 03, 2014 Filed Mar 4, 2014 22:18 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 2,500 | $50.03 | $125,085.00 |
DisclosureSEC source: 0001179110-14-004349 · edgar.xml · nonDerivative · entry 4 Schumacher Laura J · CIK 0001319245 · EVP, Bus.Dev.,Ext.Aff.&GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,585 Read SEC document |
| March 03, 2014 Filed Mar 4, 2014 22:18 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 100 | $50.03 | $5,003.10 |
DisclosureSEC source: 0001179110-14-004349 · edgar.xml · nonDerivative · entry 3 Schumacher Laura J · CIK 0001319245 · EVP, Bus.Dev.,Ext.Aff.&GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,085 Read SEC document |
| March 03, 2014 Filed Mar 4, 2014 22:18 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 1,543 | $50.03 | $77,196.29 |
DisclosureSEC source: 0001179110-14-004349 · edgar.xml · nonDerivative · entry 2 Schumacher Laura J · CIK 0001319245 · EVP, Bus.Dev.,Ext.Aff.&GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,185 Read SEC document |
| February 28, 2014 Filed Mar 4, 2014 22:18 UTC | AbbVie Inc. ABBV · Entity 2800 | Tax withholdingCommon stock, $0.01 par value | 21,940 | $50.91 | $1,116,965.40 |
DisclosureSEC source: 0001179110-14-004349 · edgar.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · EVP, Bus.Dev.,Ext.Aff.&GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 277,728 Read SEC document |
| February 20, 2014 Filed Feb 24, 2014 22:21 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantOption (right to buy) · Derivative | 94,140 | $0.00 Strike: $51.42 | $0.00 |
DisclosureSEC source: 0001179110-14-003479 · edgar.xml · derivative · entry 3 Schumacher Laura J · CIK 0001319245 · EVP, Bus.Dev.,Ext.Aff.&GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,140 Underlying: Common stock · 94,140 shares Expires 2024-02-19 F2 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exerciseable in annual increments of 31,380 on 02/20/2015, 31,380 on 02/20/2016, and 31,380 on 02/20/2017. Read SEC document |
| February 20, 2014 Filed Feb 24, 2014 22:21 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon stock, $0.01 par value | 54,590 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-003479 · edgar.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · EVP, Bus.Dev.,Ext.Aff.&GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 302,793 F1 · shares: These securities represent performance vested restricted stock awards under the AbbVie 2013 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon AbbVie reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 18, 2014 Filed Feb 19, 2014 22:35 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionOption (right to buy) · Derivative | 8,928 | $0.00 Strike: $43.21 | $0.00 |
DisclosureSEC source: 0001179110-14-003088 · edgar.xml · derivative · entry 3 Schumacher Laura J · CIK 0001319245 · EVP, Bus.Dev.,Ext.Aff.&GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 8,928 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 18, 2014 Filed Feb 19, 2014 22:35 UTC | AbbVie Inc. ABBV · Entity 2800 | Tax withholdingCommon stock, $0.01 par value | 8,021 | $50.73 | $406,905.33 |
DisclosureSEC source: 0001179110-14-003088 · edgar.xml · nonDerivative · entry 2 Schumacher Laura J · CIK 0001319245 · EVP, Bus.Dev.,Ext.Aff.&GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,203 Read SEC document |
| February 18, 2014 Filed Feb 19, 2014 22:35 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionCommon stock, $0.01 par value | 8,928 | $43.21 | $385,778.88 |
DisclosureSEC source: 0001179110-14-003088 · edgar.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · EVP, Bus.Dev.,Ext.Aff.&GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,224 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 05, 2014 Filed Feb 24, 2014 22:21 UTC | AbbVie Inc. ABBV · Entity 2800 | GiftCommon stock, $0.01 par value | 3,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-003479 · edgar.xml · nonDerivative · entry 2 Schumacher Laura J · CIK 0001319245 · EVP, Bus.Dev.,Ext.Aff.&GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,668 Read SEC document |
| August 16, 2013 Filed Aug 20, 2013 21:10 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantOption (right to buy) · Derivative | 3,582 | $0.00 Strike: $43.21 | $0.00 |
DisclosureSEC source: 0001179110-13-013320 · edgar.xml · derivative · entry 10 Schumacher Laura J · CIK 0001319245 · EVP, Bus.Dev.,Ext.Aff.&GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,582 Underlying: Common stock · 3,582 shares Expires 2014-02-19 F1 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 16, 2013 Filed Aug 20, 2013 21:10 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantOption (right to buy) · Derivative | 4,473 | $0.00 Strike: $43.21 | $0.00 |
DisclosureSEC source: 0001179110-13-013320 · edgar.xml · derivative · entry 9 Schumacher Laura J · CIK 0001319245 · EVP, Bus.Dev.,Ext.Aff.&GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,473 Underlying: Common stock · 4,473 shares Expires 2014-02-19 F1 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 16, 2013 Filed Aug 20, 2013 21:10 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantOption (right to buy) · Derivative | 873 | $0.00 Strike: $43.21 | $0.00 |
DisclosureSEC source: 0001179110-13-013320 · edgar.xml · derivative · entry 8 Schumacher Laura J · CIK 0001319245 · EVP, Bus.Dev.,Ext.Aff.&GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 873 Underlying: Common stock · 873 shares Expires 2014-02-19 F1 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 16, 2013 Filed Aug 20, 2013 21:10 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionOption (right to buy) · Derivative | 4,011 | $0.00 Strike: $34.49 | $0.00 |
DisclosureSEC source: 0001179110-13-013320 · edgar.xml · derivative · entry 7 Schumacher Laura J · CIK 0001319245 · EVP, Bus.Dev.,Ext.Aff.&GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 4,011 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2013 Filed Aug 20, 2013 21:10 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionOption (right to buy) · Derivative | 5,425 | $0.00 Strike: $28.91 | $0.00 |
DisclosureSEC source: 0001179110-13-013320 · edgar.xml · derivative · entry 6 Schumacher Laura J · CIK 0001319245 · EVP, Bus.Dev.,Ext.Aff.&GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 5,425 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2013 Filed Aug 20, 2013 21:10 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionOption (right to buy) · Derivative | 1,039 | $0.00 Strike: $30.21 | $0.00 |
DisclosureSEC source: 0001179110-13-013320 · edgar.xml · derivative · entry 5 Schumacher Laura J · CIK 0001319245 · EVP, Bus.Dev.,Ext.Aff.&GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 1,039 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2013 Filed Aug 20, 2013 21:10 UTC | AbbVie Inc. ABBV · Entity 2800 | Tax withholdingCommon stock, $0.01 par value | 8,928 | $43.21 | $385,778.88 |
DisclosureSEC source: 0001179110-13-013320 · edgar.xml · nonDerivative · entry 4 Schumacher Laura J · CIK 0001319245 · EVP, Bus.Dev.,Ext.Aff.&GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,296 Read SEC document |
| August 16, 2013 Filed Aug 20, 2013 21:10 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionCommon stock, $0.01 par value | 4,011 | $34.49 | $138,334.98 |
DisclosureSEC source: 0001179110-13-013320 · edgar.xml · nonDerivative · entry 3 Schumacher Laura J · CIK 0001319245 · EVP, Bus.Dev.,Ext.Aff.&GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,224 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2013 Filed Aug 20, 2013 21:10 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionCommon stock, $0.01 par value | 5,425 | $28.91 | $156,862.79 |
DisclosureSEC source: 0001179110-13-013320 · edgar.xml · nonDerivative · entry 2 Schumacher Laura J · CIK 0001319245 · EVP, Bus.Dev.,Ext.Aff.&GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,213 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2013 Filed Aug 20, 2013 21:10 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionCommon stock, $0.01 par value | 1,039 | $30.21 | $31,391.83 |
DisclosureSEC source: 0001179110-13-013320 · edgar.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · EVP, Bus.Dev.,Ext.Aff.&GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,788 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2013 Filed Aug 2, 2013 21:10 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionOption (right to buy) · Derivative | 5,634 | $0.00 Strike: $32.57 | $0.00 |
DisclosureSEC source: 0001179110-13-012603 · edgar.xml · derivative · entry 5 Schumacher Laura J · CIK 0001319245 · EVP, Bus.Dev.,Ext.Aff.&GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 5,634 shares Expires 2013-08-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2013 Filed Aug 2, 2013 21:10 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionOption (right to buy) · Derivative | 774 | $0.00 Strike: $32.57 | $0.00 |
DisclosureSEC source: 0001179110-13-012603 · edgar.xml · derivative · entry 4 Schumacher Laura J · CIK 0001319245 · EVP, Bus.Dev.,Ext.Aff.&GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 774 shares Expires 2013-08-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2013 Filed Aug 2, 2013 21:10 UTC | AbbVie Inc. ABBV · Entity 2800 | Tax withholdingCommon stock, $0.01 par value | 5,443 | $45.48 | $247,547.64 |
DisclosureSEC source: 0001179110-13-012603 · edgar.xml · nonDerivative · entry 3 Schumacher Laura J · CIK 0001319245 · EVP, Bus.Dev.,Ext.Aff.&GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,749 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.